Self-testing Market - By Product Type (Kits, Devices, Strips), Sample Type (Blood, Urine), Usage (Disposable, Reusable), By Application (Blood Glucose Test, Pregnancy Test, Allergy Test), Test Type, Distribution Channel – Global Forecast 2024-2032

Self-testing Market - By Product Type (Kits, Devices, Strips), Sample Type (Blood, Urine), Usage (Disposable, Reusable), By Application (Blood Glucose Test, Pregnancy Test, Allergy Test), Test Type, Distribution Channel – Global Forecast 2024-2032

Self-testing Market Size

Self-testing Market was valued at around USD 15 billion in 2023 and is estimated to expand at 6.7% CAGR from 2024 to 2032. Preventive healthcare, rise in chronic diseases, aging population, convenience and accessibility offered by self-testing kits are some of the key factors fueling the market growth. The growing emphasis on preventive healthcare encourages individuals to monitor their health regularly, driving the demand for self-testing as a proactive approach to well-being.
 

Additionally, the trend towards personalized medicine, including genetic testing and tailored health recommendations, contributes to the popularity of self-testing for obtaining individualized health insights. For instance, in July 2023, Quest Diagnostics launched 'Genetic Insights', its first consumer-initiated genetic test. These tests will be made available to users through company's consumer health portal questhealth.com. Moreover, the rise of e-commerce and digital health platforms facilitates the easy distribution and accessibility of self-testing kits, making it more convenient for consumers to purchase and use these products.
 

Self-testing refers to the process of individuals conducting diagnostic or screening tests on themselves without the direct involvement of healthcare professionals. This practice allows individuals to monitor various aspects of their health, wellness, or specific medical conditions using self-administered testing kits or devices.
 

COVID-19 Impact

The COVID-19 pandemic acted as a catalyst in promoting the widespread adoption of at-home or self-testing kits. The pandemic highlighted the importance of rapid and accessible testing for infectious diseases. This led to a surge in demand for self-testing kits for COVID-19, allowing individuals to test themselves at home, reducing the burden on healthcare facilities. The success and demand for COVID-19 self-testing prompted companies to expand their product offerings in the market. This includes the development of new self-testing solutions for various health parameters.
 

Self-testing Market Trends

Technological advancements have led to the development of self-test kits with improved accuracy and reliability. Advanced biosensors, diagnostic technologies, and algorithms contribute to more precise test results, increasing confidence among users.
 

• Advance and modern self-test kits integrate seamlessly with digital health platforms and mobile applications. This integration allows users to track and monitor their test results digitally, providing a more comprehensive and accessible overview of their health status.
   
• For instance, in October 2023, PHASE Scientific Americas, a global biomedical company focusing on offering innovative healthcare diagnostics solutions launched INDICAID health, company's at-home health tests and digital health experiences. After obtaining the test results, the users can get required guidance or treatment advise through company's virtual platform. Such developments will further boost the product adoption rate.
   
• Some self-test kits enable multiple testing, allowing a single self-test kit to assess multiple health parameters simultaneously. This enhances the efficiency of testing and provides a more comprehensive health profile.
   

Self-testing Market Analysis

The market by product type is segmented into kits, devices, and strips. The kits segment is further divided into self-testing kits, and self-collection kits. The kits segment accounted for majority revenue share and was valued at around USD 6.4 billion revenue in 2023.
 

• Kits are designed to be user-friendly, with clear instructions and all components neatly organized. This simplicity appeals to consumers who may not be familiar with the technical aspects of individual devices and strips.
   
• Self-testing kits can cater to a wide range of tests and health parameters within a single product. This versatility allows consumers to address different health concerns with a single purchase.
   
• Consumers may perceive self-testing kits as offering better value for money compared to purchasing individual devices and strips separately.
   

Based on sample type, the self-testing market is categorized into blood, urine, saliva, and other sample types. The blood segment held leading market share in 2023 and is anticipated to record significant growth rate to reach around USD 11 billion in 2032.
 

• Blood-based tests provide insights into various health indicators, contributing to proactive health management. Blood-based self-testing allows for the early detection of potential health issues, promoting a proactive approach to well-being.
   
• Individuals with chronic conditions, such as diabetes or cardiovascular diseases, often require regular monitoring of blood parameters. Blood sample-based self-testing kits offer a convenient way for these individuals to manage their health at home. Moreover, blood sample-based kits cater to a broad range of tests, including lipid profiles, glucose levels, and various biomarkers.
   
• The COVID-19 pandemic has highlighted the importance of blood-based testing for infectious diseases. Home-based blood antibody tests became popular for assessing prior exposure to the virus.
   

The self-testing market by usage is categorized into disposable, and reusable. The disposable segment accounted for larger share and was valued at over USD 12.6 billion revenue in 2023.
 

• Disposable kits are often designed for simplicity and ease of use. Users can perform the test without the need for complex preparation or cleaning procedures, making them more convenient for at-home testing.
   
• The use of disposable components minimizes the risk of cross-contamination between different tests or users. This is essential for maintaining the accuracy and reliability of test results.
   
• The increased awareness of infection control during the COVID-19 pandemic has boosted the demand for disposable self-testing kits, especially for at-home testing and point-of-care settings.
   

Based on application, the self-testing market is divided into blood glucose test, pregnancy test, allergy test, STD /STI test, cancer test, drug abuse testing, genetic testing, cholesterol and triglycerides tests, urinary tract infection testing, other applications. The allergy test segment held significant revenue share and was valued at around USD 6.3 billion in 2032.
 

• Allergies, including food allergies, environmental allergies, and sensitivities, are on the rise globally. This increase in allergic conditions has led to a greater demand for self-testing options. For instance, self-testing kits that focus on food sensitivities, including common ingredients such as gluten or dairy, are particularly popular. Individuals with suspected food sensitivities use these kits to explore dietary adjustments.
   
• Growing awareness of allergen sensitivity and its impact on overall health has contributed to the demand for self-testing kits. Individuals are more likely to seek ways to identify and manage allergens affecting their well-being.
   

The self-testing market by test type is categorized into laboratory tests and home-based tests. The home-based tests segment accounted for majority share and was valued at over USD 13.1 billion revenue in 2023.
 

• Some individuals prefer the privacy of home-based testing, avoiding potential discomfort or embarrassment associated with laboratory-based testing. This is particularly relevant for tests related to sensitive health conditions.
   
• For conditions that require frequent monitoring, such as blood glucose levels or fertility tracking, home-based testing kits provide a practical solution. Users can integrate testing into their daily routines.
   
• Advances in technology have enabled the development of home-based testing kits for a wide range of health parameters, including infectious diseases, genetic testing, wellness markers, and more. This broad range of available tests contributes to increased demand.
   

Based on distribution channel, the self-testing market by is segmented into brick-and-mortar stores, and ecommerce. The brick-and-mortar stores segment accounted for majority revenue share and was valued at around USD 10 billion revenue in 2023.
 

• Physical retail locations offer the opportunity for self-testing kits to be prominently displayed and promoted. Some consumers prefer the immediate gratification of purchasing self-testing kits in-store. They can obtain the product instantly without waiting for shipping, making it suitable for those who want quick access to testing solutions.
   
• Additionally, in-store staff can provide face-to-face assistance and information about self-testing kits, addressing consumer questions and concerns. This personalized interaction contributes to consumer education and promotes product understanding.
   

North America self-testing market accounted for USD 4.8 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The growing emphasis on consumer empowerment in healthcare has led individuals in North America to seek tools that enable them to actively participate in monitoring and managing their health. Self-testing kits provide a means for individuals to take control of certain aspects of their well-being.
   
• Moreover, the prevalence of chronic diseases, including diabetes and cardiovascular conditions, in the region has contributed to the adoption of self-testing kits. These kits allow individuals to monitor specific health parameters regularly, facilitating proactive management of chronic conditions.
   
• Furthermore, advances in technology, including the development of user-friendly devices, smartphone applications, and digital health platforms, have made self-testing more accessible and attractive to regional consumers.
   

Self-testing Market Share

The self-testing industry is diverse, with companies offering solutions for various health parameters, including blood glucose, cholesterol, infectious diseases, fertility, and genetic testing. The market is characterized by ongoing innovation, technological advancements, and an increasing focus on providing user-friendly, accurate, and accessible testing options for consumers. Some of the leading industry players including F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Quidel Corporation, Johnson & Johnson Services, Inc., and Piramal Enterprises Ltd. among others have a notable presence in the market.
 

Self-testing Market Companies

Some of the eminent market participants operating in the blood screening industry include

• F. Hoffmann-La Roche Ltd.
• Piramal Enterprises Ltd.
• Becton, Dickinson and Company
• PRIMA Lab SA
• B. Braun Melsungen AG
• Alere Inc.
• Cardinal Health
• Quidel Corporation
• Abbott Laboratories
• OraSure Technologies, Inc.
• Nectar Lifesciences Ltd.
• Johnson & Johnson Services, Inc.
   

Self-testing Industry News

• In May 2022, Labcorp launched first-of-its-kind, at-home collection device for diabetes risk testing. The users can measure their hemoglobin A1c (HbA1c) levels from a small blood sample through the collection kit 'Labcorp OnDemand'. Such product launches will improve company's product portfolio as well as revenue generating prospects.
   
• In January 2022, Roche Diagnostics India launched their 'COVID-19 At-home Test'. It is an OTC product intended to be used for detection of SARS CoV-2 infection in individuals with associated virus symptoms. It is available across e-pharmacies and local pharmacies without any prescription.
   

Self-testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product Type, 2018-2032 (USD Million)

• Kits
• Self-testing kits
• Self-collection kits 
• Devices
• Strips

By Sample Type, 2018-2032 (USD Million)

• Blood
• Urine
• Saliva
• Other sample types

By Usage, 2018-2032 (USD Million)

• Disposable
• Reusable

By Application, 2018-2032 (USD Million)

• Blood glucose test
• Pregnancy test
• Allergy test
• STD /STI test
• Cancer test
• Drug abuse testing
• Genetic testing
• Cholesterol and triglycerides tests
• Urinary tract infection testing
• Other applications

By Test Type, 2018-2032 (USD Million)

• Laboratory tests
• Home-based tests

By Distribution Channel, 2018-2032 (USD Million)

• Brick and mortar stores
• Ecommerce

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa